Skip to main content
. Author manuscript; available in PMC: 2021 Oct 29.
Published in final edited form as: Ophthalmology. 2019 Jan 28;126(6):792–800. doi: 10.1016/j.ophtha.2019.01.024

Table 1.

Study Population Characteristics

CyclASol 0.05% CyclASol 0.1% Vehicle Restasis
Randomized patients, n 51 51 52 53
Patients completing the study, n (%) 50 (98.0) 50 (98.0) 48 (92.3) 52 (98.1)
Patients discontinuing the study, n (%) 1 (2.0) 1 (2.0) 4 (7.7) 1 (1.9)
Reason for discontinuation, n (%)
 Adverse events 1 (2.0) 0 2 (3.8) 1 (1.9)
 Subject choice 0 0 2 (3.8) 0
 Other 0 1 (2.0) 0 0